Last reviewed · How we verify
Carbamazepine ER Tablet (carbamazepine-er-tablet)
At a glance
| Generic name | carbamazepine-er-tablet |
|---|---|
| Sponsor | Pfizer Inc. |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- To Assess the Enzyme Inducing Effects of Carbamazepine on the PK of Mirdametinib in Healthy Participants (PHASE1)
- A Study to Learn if the Study Medicine Called Carbamazepine Changes How the Body Processes PF-07220060 (PHASE1)
- A Study to Learn If the Study Medicine Called Carbamazepine Changes How the Body Processes the Other Study Medicine Ibuzatrelvir in Healthy Adults (PHASE1)
- Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Carbamazepine ER Tablet CI brief — competitive landscape report
- Carbamazepine ER Tablet updates RSS · CI watch RSS
- Pfizer Inc. portfolio CI